Fund structure

Fund structure09.17.2021

Aescap Life Sciences
Aescap Genetics
Performance
Fund structure
Fund management
Fund setup

Attend our meetings

News

Aescap Genetics Newsletter Q1 2022 April 12, 2022
Aescap Life Sciences Newsletter Q1 2022 April 12, 2022
Aescap Life Sciences Quarterly Update Q4 2021 January 7, 2022

Aescap
Barbara Strozzilaan 101, 1083 HN Amsterdam, Nederland
Tel. + 31 20 570 29 40 E-mail: service@aescap.com
Alle rechten voorbehouden. © 2022

Do not run any unnecessary risk. Read the Key Information Document and the Key Investor Information Document of the Funds. This communication is neither an offer to sell nor a solicitation to invest. Past performance is not indicative of future results. The value of investments and any income generated may go down as well as up and is not guaranteed. Privium Fund Management B.V. (Privium) is authorized and regulated by the Dutch Authority for the Financial Markets (www.afm.nl) as an Alternative Investment Fund Manager (AIFM). The Funds and its manager, Privium Fund Management B.V., are held in the register of Dutch Authority for the Financial Markets. The Prospectus of the Funds, the Key Information Documents and the Key Investor Information Documents can be downloaded via the website of the Funds (www.aescap.com) and the Fund Manager (www.priviumfund.com). The performance overviews shown in this communication have been carefully composed by Privium Fund Management B.V. No rights can be derived from this communication.